Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
4-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
4-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Journals
Journal #26
advertisement
American Journal of Ophthalmology
14
Showing records 1 to 14 |
Display all abstracts in
American Journal of Ophthalmology
8221
Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St Lucia, West Indies
Wilson MR; Kosoko O; Cowan Jr CL; Sample PA; Johnson CA; Haynatzki G; Enger C; Crandall D
American Journal of Ophthalmology
2002; 134: 399-405
8254
A case-control comparison of the clinical characteristics of glaucoma and ocular hypertensive patients with and without the myocilin Gln368Stop mutation
Graul TA; Kwon YH; Zimmerman MB; Kim CS; Sheffield VC; Stone EM; Alward WLM
American Journal of Ophthalmology
2002; 134: 884-890
8177
Optical coherence tomography measurement of nerve fiber layer thickness and the likelihood of a visual field defect
Williams ZY; Schuman JS; Gamell L; Nemi A; Hertzmark E; Fujimoto JG; Mattox C; Simpson J; Wollstein G
American Journal of Ophthalmology
2002; 134: 538-546
8256
Morphometric change analysis of the optic nerve head in unilateral disc hemorrhage cases
Ahn JK; Park KH
American Journal of Ophthalmology
2002; 234: 920
8167
Anisometropia and degree of optic nerve damage in chronic open-angle glaucoma
Jonas JB; Martus P; Budde WM
American Journal of Ophthalmology
2002; 134: 547-551
8129
Performance of glaucoma mass screening with only a visual field test using frequency-doubling technology perimetry
Iwasaki A; Sugita M
American Journal of Ophthalmology
2002; 134: 529-537
8124
The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma
The AGIS Investigators
American Journal of Ophthalmology
2002; 134: 499-512
8098
The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study
Newman NJ; Scherer R; Langenberg P; Kelman S; Feldon S; Kaufman D; Dickersin K
American Journal of Ophthalmology
2002; 134: 317-328
8253
Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment
Lama PJ
American Journal of Ophthalmology
2002; 134: 749-760
8255
Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure
Jampel HD; Bacharach J; Sheu WP; Wohl LG; Solish AM; Christie W
American Journal of Ophthalmology
2002; 134: 863-871
8079
Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma
Sponsel WE; Paris G; Trigo Y; Pena M
American Journal of Ophthalmology
2002; 134: 552-559
8056
The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty
The AGIS Investigators
American Journal of Ophthalmology
2002; 134: 481-498
8039
A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy
WuDunn D; Cantor LB; Palanca-Capistrano AM; Hoop J; Alvi NP; Finley C; Lakhani V; Burnstein A; Knotts SL
American Journal of Ophthalmology
2002; 134: 521-528
8017
Comparison of surgical outcomes of combined viscocanalostomy and cataract surgery with combined trabeculotomy and cataract surgery
Tanito M; Park M; Nishikawa M; Ohira A; Chihara E
American Journal of Ophthalmology
2002; 134: 513-520
Issue
4-3
Table of Contents
Editor's Selection
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept